» Articles » PMID: 25749370

Quantitative Assessment of Telomerase Components in Cancer Cell Lines

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 2015 Mar 10
PMID 25749370
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Besides its canonical function of catalyzing the formation of telomeric repeats, many groups have recently reported non-canonical functions of hTERT in particular, and telomerase in general. Regulating transcription is the central basis of non-canonical functions of telomerase. However, unlike reverse transcriptase activity of telomerase that requires only a few molecules of enzymatically active hTERT, non-canonical functions of hTERT or other telomerase components theoretically require several hundred copies. Here, we provide the first direct quantification of all the telomerase components in human cancer cell lines. We demonstrate that telomerase components do not exist in a 1:1 stoichiometric ratio, and there are several hundred copies of hTERT in cells. This provides the molecular basis of hTERT to function in other signaling cascades, including transcription.

Citing Articles

The TERT Promoter is Polycomb-Repressed in Neuroblastoma Cells with Long Telomeres.

Graham M, Xu B, Davis C, Meeker A, Heaphy C, Yegnasubramanian S Cancer Res Commun. 2024; 4(6):1533-1547.

PMID: 38837897 PMC: 11188873. DOI: 10.1158/2767-9764.CRC-22-0287.


Telomeres expand sphere of influence: emerging molecular impact of telomeres in non-telomeric functions.

Vinayagamurthy S, Bagri S, Mergny J, Chowdhury S Trends Genet. 2022; 39(1):59-73.

PMID: 36404192 PMC: 7614491. DOI: 10.1016/j.tig.2022.10.002.


The Role of Telomerase in Breast Cancer's Response to Therapy.

Judasz E, Lisiak N, Kopczynski P, Taube M, Rubis B Int J Mol Sci. 2022; 23(21).

PMID: 36361634 PMC: 9654063. DOI: 10.3390/ijms232112844.


Targeting telomerase reverse transcriptase with the covalent inhibitor NU-1 confers immunogenic radiation sensitization.

Liu Y, Betori R, Pagacz J, Frost G, Efimova E, Wu D Cell Chem Biol. 2022; 29(10):1517-1531.e7.

PMID: 36206753 PMC: 9588800. DOI: 10.1016/j.chembiol.2022.09.002.


Identification of mechanism of cancer-cell-specific reactivation of hTERT offers therapeutic opportunities for blocking telomerase specifically in human colorectal cancer.

Akincilar S, Chua J, Ng Q, Chan C, Eslami-S Z, Chen K Nucleic Acids Res. 2022; 51(1):1-16.

PMID: 35697349 PMC: 9841410. DOI: 10.1093/nar/gkac479.